<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">735</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2021-29-s2-1292-1297</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>THE QUALITY INDICATORS TO ASSESS THE PROSTATE CANCER RADIOTHERAPY PERFORMANCE (BRIEF REVIEW)</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Andreev</surname><given-names>D. A.</given-names></name><bio></bio><email>andreevda@zdrav.mos.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zavyalov</surname><given-names>A. A.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department</aff><pub-date date-type="epub" iso-8601-date="2021-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2021</year></pub-date><volume>29</volume><issue>S2</issue><fpage>1292</fpage><lpage>1297</lpage><history><pub-date date-type="received" iso-8601-date="2021-11-23"><day>23</day><month>11</month><year>2021</year></pub-date></history><permissions><copyright-statement>Copyright © 2021,</copyright-statement><copyright-year>2021</copyright-year></permissions><abstract>Introduction. The radiation therapy (RT) plays a tremendous role in the consistent treatment of prostate cancer (PCa). The research ideas underpinning the wide implementation of innovative digitalized continuous (nonstop) dynamic auditing are coming true. Simultaneously, there are increasing challenges in selection of RT quality indicators.Objective: to study the pivotal indicators for RT quality assurance in treatment of PCa and to highlight the breaking through developments securing the delivery of top-quality cancer care in radiation oncology units.Materials and methods. The literature search was performed in the PubMed database and the Google system. The inquiries included such terms as: “quality of care”, “quality assessment criteria”, “indicators”, “prostate cancer” and “radiation therapy”. A logical and semantic approaches were applicated to select the relevant scientific resources.Results. In most relevant studies, the variations of the Delphi technique are used to choose the quality assessment criteria. The targeted research papers describe the development of QIs for assessing the quality of radiation therapy in patients with locally advanced PCa; a hierarchical list of QIs has been generated. The adequate registration of information has huge impact on quality assessment to draw the definitive thorough conclusions.Discussion. The further improvement of Delphi technique may form one of pillars for the development of valuable RT quality measures. Considering the math aspects and the physical nature of RT, it seems being important to include the key opinion leaders in the field of clinical oncoinformatics, radiation informatics, and specialists from technical industries in the expert committees for the selection of RT QIs.</abstract><kwd-group xml:lang="en"><kwd>quality of medical care</kwd><kwd>quality assessment criteria</kwd><kwd>indicators</kwd><kwd>prostate cancer</kwd><kwd>radiation therapy</kwd><kwd>radiation informatics</kwd><kwd>clinical oncoinformatics</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>качество медицинской помощи</kwd><kwd>критерии оценки качества</kwd><kwd>индикаторы</kwd><kwd>рак предстательной железы</kwd><kwd>лучевая терапия</kwd><kwd>клиническая онкоинформатика</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Informatics in radiation oncology / Starkshall G., Siochi R. (eds.). Boca Raton, 2014. 329 p. DOI: 10.1118/1.3613496.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Dunn J., Goodwin B., Aitken J. F. et al. Are National Cancer Control Indicators for patient experiences being met in regional and remote Australia? A cross-sectional study of cancer survivors who travelled for treatment // BMJ Open. 2021. Vol. 11, N 2. P. e042507. DOI: 10.1136/bmjopen-2020-042507.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Reitblat C., Bain P. A., Porter M. E. et al. Value-based healthcare in urology: a collaborative review // Eur. Urol. 2021. Vol. 79, N 5. P. 571-585. DOI: 10.1016/j.eururo.2020.12.008.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Dawda P. CareTrack: assessing the appropriateness of health care delivery in Australia // Med. J. Aust. 2012. Vol. 197, N 10. P. 548-550. DOI: 10.5694/mja12.11149.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Abratt R. P., Rautenbach M., Govender Y., Oelofse I. A quality improvement programme in radiotherapy using workflow audits // S. Afr. Med. J. 2021. Vol. 111, N 2. P. 106-109. DOI: 10.7196/SAMJ.2021.v111i2.15310.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Donabedian A. The quality of medical care: a concept in search of a definition // J. Fam. Pract. 1979. Vol. 9, N 2. P. 277-284.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Men K., Geng H., Biswas T. et al. Automated quality assurance of OAR contouring for lung cancer based on segmentation with deep active learning // Front. Oncol. 2020. Vol. 10. P. 986. DOI: 10.3389/fonc.2020.00986.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Johnston E. E., Martinez I., Wolfe J., Asch S. M. Quality measures for end-of-life care for children with cancer: a modified Delphi approach // Cancer. 2021. Vol. 127, N 14. P. 2571-2578. DOI: 10.1002/cncr.33546.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Pooni A., Schmocker S., Brown C. et al. Quality indicator selection for the Canadian Partnership against Cancer rectal cancer project: A modified Delphi study // Colorectal Dis. 2021. Vol. 23, N 6. P. 1393-1403. DOI: 10.1111/codi.15599.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Andreano A., Valsecchi M. G., Russo A. G., Siena S. Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases // Arch. Public Health. 2021. Vol. 79, N 1. P. 12. DOI: 10.1186/s13690-021-00528-0.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Danielson B., Brundage M., Pearcey R. et al. Development of indicators of the quality of radiotherapy for localized prostate cancer // Radiother. Oncol. 2011. Vol. 99, N 1. P. 29-36. DOI: 10.1016/j.radonc.2011.02.013.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Nag N., Millar J., Davis I. D. et al. Development of indicators to assess quality of care for prostate cancer // Eur. Urol. Focus. 2018. Vol. 4, N 1. P. 57-63. DOI: 10.1016/j.euf.2016.01.016.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Merriel S. W. D., Moon D., Dundee P. et al. A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance // BMC Urol. 2021. Vol. 21, N 1. P. 18. DOI: 10.1186/s12894-021-00789-5.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Soon Y. Y., Chen D., Tan T. H., Tey J. Quality of radiotherapy reporting in randomized controlled trials of prostate cancer // Radiat. Oncol. 2018. Vol. 13, N 1. P. 108. DOI: 10.1186/s13014-018-1053-7.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ohri N., Shen X., Dicker A. P. et al. Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials // J. Natl. Cancer Inst. 2013. Vol. 105, N 6. P. 387-393. DOI: 10.1093/jnci/djt001.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>The Current Status of Radiological Clinical Audit and Feedback on the ESR Guide to Clinical Audit in Radiology and the ESR Clinical Audit Tool (Esperanto) - an ESR Survey of European Radiology Departments // Insights Imaging. 2020. Vol. 11, N 1. P. 37. DOI: 10.1186/s13244-020-00843-0.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Ebdon-Jackson S., Frija G. Improving justification of medical exposures using ionising radiation: considerations and approaches from the European Society of Radiology // Insights Imaging. 2021. Vol. 12, N 1. P. 2. DOI: 10.1186/s13244-020-00940-0.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Hernandez V., Hansen C. R., Widesott L. et al. What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans // Radiother. Oncol. 2020. Vol. 153. P. 26-33. DOI: 10.1016/j.radonc.2020.09.038.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Emert F., Missimer J., Eichenberger P. A. et al. Enhanced deep-inspiration breath hold superior to high-frequency percussive ventilation for respiratory motion mitigation: a physiology-driven, MRI-guided assessment toward optimized lung cancer treatment with proton therapy // Front. Oncol. 2021. Vol. 11. P. 621350. DOI: 10.3389/fonc.2021.621350.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Hu Y., Ding X., Shen J. et al. Feasibility of using megavoltage computed tomography to reduce proton range uncertainty: a simulation study // J. Appl. Clin. Med. Phys. 2021. Vol. 22, N 3. P. 31-140. DOI: 10.1002/acm2.13191.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Yaparpalvi R., Garg M. K., Shen J. et al. Evaluating which plan quality metrics are appropriate for use in lung SBRT // Br. J. Radiol. 2018. Vol. 91, N 1083. P. 20170393. DOI: 10.1259/bjr.20170393.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Monti S., Palma G., D’Avino V. et al. Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients // Sci. Rep. 2017. Vol. 7, N 1. P. 7220. DOI: 10.1038/s41598-017-07586-x.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Liang B., Yan H., Tian Y. et al. Dosiomics: Extracting 3D spatial features from dose distribution to predict incidence of radiation pneumonitis // Front. Oncol. 2019. Vol. 9. P. 269. DOI: 10.3389/fonc.2019.00269.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Lakshminarayanan P., Jiang W., Robertson S. P. et al. Radio-morphology: Parametric shape-based features in radiotherapy // Med. Phys. 2019. Vol. 46, N 2. P. 704-713. DOI: 10.1002/mp.13323.</mixed-citation></ref></ref-list></back></article>
